Blackston Financial Advisory Group »

Relmada Therapeutics shares owned by Blackston Financial Advisory Group

Quarter-by-quarter ownership of Relmada Therapeutics (RLMD) shares owned by Blackston Financial Advisory Group from 13F filings

Historical chart of Blackston Financial Advisory Group investment in Relmada Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Relmada Therapeutics held by Blackston Financial Advisory Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Relmada Therapeutics by Blackston Financial Advisory Group

Quarter filed Position value Share count Share price at filing
2024-03-31 $9 2 4.50

More positions owned by Blackston Financial Advisory Group

Vanguard World Mega Grwth Ind (MGK)
Vanguard Index Fds Total Stk Mkt (VTI)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Vanguard Specialized Funds Div App Etf (VIG)
Vanguard Index Fds Large Cap Etf (VV)
Vanguard World Consum Stp Etf (VDC)
Vanguard Scottsdale Fds Vng Rus1000idx (VONE)
Vanguard Whitehall Fds High Div Yld (VYM)
Vanguard Index Fds Mid Cap Etf (VO)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Vanguard World Inf Tech Etf (VGT)
Microsoft Corporation (MSFT)
Apple (AAPL)
Vanguard Scottsdale Fds Vng Rus1000grw (VONG)
Tesla Motors (TSLA)

View all positions for Blackston Financial Advisory Group

Top funds holding Relmada Therapeutics

Vanguard Group
Acadian Asset Management
Parsons Capital Management
Opaleye Management
Palo Alto Investors
Franklin Resources
BlackRock
Millennium Management
Two Sigma Advisers
Geode Capital Management
Two Sigma Investments
Deutsche Bank Aktiengesellschaft
Bank of America Corporation
Marshall Wace
Bridgeway Capital Management

View all funds holding Relmada Therapeutics